Heart failure with preserved ejection fraction
Conditions
Interventions
HFpEF patients group:None
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with the HFpEF diagnostic criteria of qi deficiency and blood stasis syndrome. 2. Age = 40 years. 3. Patients who receive standard drug treatment for heart failure and are currently in stable condition. 4. Those who voluntarily participate and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with acute coronary syndrome. 2. Congenital heart disease, severe valvular heart disease, constrictive pericarditis, hypertrophic cardiomyopathy, limited (invasive) cardiomyopathy, etc. 3. Patients with a history of stent implantation and coronary artery bypass grafting in the past 90 days. 4. Patients who have been implanted with permanent pacemakers, implantable defibrillators or left ventricular assist devices in the past 90 days. 5. Systolic blood pressure (SBP) > 160mmHg or < 90mmHg when selected. 6. Patients with chronic lung disease who need oxygen therapy or drug intervention. 7. The death of cerebral infarction occurred in the past 90 days. 8. Patients with other diseases (such as severe failure of important organs such as liver and kidney, malignant tumor, etc.) need special treatment during treatment, which affect the clinical treatment of heart failure. 9. During pregnancy, lactation, or women of childbearing age but do not use reliable contraceptive methods. 10. The researchers judged that the patients had poor compliance and were unable to complete the trial. 11. Those who have participated in other clinical trials in the past 2 months (the hospitalized patients are calculated according to the time of admission).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral blood biomarkers; | — |
Countries
China
Contacts
Public ContactGuanwei Fan
Outcome results
None listed